Skip to main content
Equibles

Bridgewater Associates, LP

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1350694 Westport, CT
Back to TEVA Full portfolio

Position in TEVA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$44,947,850
+$10,960,262 QoQ
Shares Held
1,326,678
+17.6% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#74
of 675 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Bridgewater Associates, LP holds $207,447,311 across 14 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (21.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 111,326 $60,319,766
2 TEVA
Teva Pharmaceutical Industries Ltd
This page 		1,326,678 $44,947,850
3 NBIX
Neurocrine Biosciences Inc
 205,677 $34,664,801
4 VTRS
Viatris Inc
 1,698,341 $26,969,655
5 ZTS
Zoetis Inc.
 134,203 $9,643,827
6 LNTH
Lantheus Holdings, Inc.
 65,941 $7,315,494
7 BCRX
Biocryst Pharmaceuticals Inc
 491,057 $4,910,570
8 BHC
Bausch Health Companies Inc.
 866,285 $4,270,785

All Filings in TEVA

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $44,947,850 1,326,678
2026-03-31 $33,987,588 1,128,406
2025-12-31 $23,535,242 754,093
2025-09-30 $17,468,596 864,782
2024-12-31 $207,021 9,393
2024-09-30 $418,460 23,222
2024-06-30 $358,767 22,078
2024-03-31 $658,386 46,661
2023-12-31 $762,892 73,074
2023-09-30 $1,984,155 194,525
2023-06-30 $1,750,800 232,510
2023-03-31 $2,147,425 242,647
2022-12-31 $2,821,883 309,417
2022-09-30 $3,585,162 444,258
2022-06-30 $3,647,523 485,043
2022-03-31 $5,084,816 541,514
2021-12-31 $4,162,148 519,619
2021-09-30 $2,680,613 275,217
2021-06-30 $2,392,523 241,669